Phase 1/2 study of ocaratuzumab, an Fc-engineered humanized anti-CD20 monoclonal antibody, in low-affinity FcγRIIIa patients with previously treated follicular lymphoma.
| Image |  |
|---|---|
| Description | scientific article published on 14 July 2014 |
| Author/s |
author: Ian W. Flinn Brian K Link Mitchell Smith |
| Publication date | July 14, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |